Albrecht von Brunn

Dr. Albrecht von Brunn

Max von Pettenkofer-Institute, Ludwig-Maximilians-University Munich, 80336 Munich, Germany

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2011 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
SPSusanne Pfefferle
Susanne Pfefferle
JSJulia Schöpf
Julia Schöpf
MKManfred Kögl
Manfred Kögl
CFCaroline C. Friedel
Caroline C. Friedel
MMMarcel A. Müller
Marcel A. Müller
ABAlbrecht von Brunn
Albrecht von Brunn
Coronaviruses (CoVs) are important human and animal pathogens that induce fatal respiratory, gastrointestinal and neurological disease. The outbreak of the severe acute respiratory syndrome (SARS) in 2002/2003 has demonstrated human vulnerability to (Coronavirus) CoV epidemics. Neither vaccines nor therapeutics are available against human and animal CoVs. Knowledge of host cell proteins that take part in pivotal virus-host interactions could define broad-spectrum antiviral targets. In this study, we used a systems biology approach employing a genome-wide yeast-two hybrid interaction screen to identify immunopilins (PPIA, PPIB, PPIH, PPIG, FKBP1A, FKBP1B) as interaction partners of the CoV non-structural protein 1 (Nsp1). These molecules modulate the Calcineurin/NFAT pathway that plays an important role in immune cell activation. Overexpression of NSP1 and infection with live SARS-CoV strongly increased signalling through the Calcineurin/NFAT pathway and enhanced the induction of interleukin 2, compatible with late-stage immunopathogenicity and long-term cytokine dysregulation as observed in severe SARS cases. Conversely, inhibition of cyclophilins by cyclosporine A (CspA) blocked the replication of CoVs of all genera, including SARS-CoV, human CoV-229E and -NL-63, feline CoV, as well as avian infectious bronchitis virus. Non-immunosuppressive derivatives of CspA might serve as broad-range CoV inhibitors applicable against emerging CoVs as well as ubiquitous pathogens of humans and livestock. Broad-range anti-infective drugs are well known against bacteria, fungi, and parasites. These pathogens maintain their own metabolism distinctive from that of the host. Broad-range drugs can be obtained by targeting elements that several of these organisms have in common. In contrast, target overlap between different viruses is minimal. The replication of viruses is highly interweaved with the metabolism of the host cell. A high potential in the development of antivirals with broad activity might therefore reside in the identification of host factors elemental to virus replication. In this work we followed a systems biology approach, screening for interactions between virus and host proteins by employing an automated yeast-two-hybrid setup. Upon binding of a viral protein to cyclophilins the screen led to the identification of the Calcineurin/NFAT pathway possibly being involved in the pathogenesis of SARS-Coronavirus. Secondly, cyclophilins were suggested to play an elemental role in virus replication since cyclosporin A inhibited replication of all Coronavirus prototype members tested. This large range of viruses includes common cold viruses, the SARS agent, as well as a range of animal viruses. For the first time this work shows that an undirected, systems-biology approach could identify a host-encoded, broad-range antiviral target.

12 August 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
YMYue Ma-Lauer
Yue Ma-Lauer
JCJavier Carbajo-Lozoya
Javier Carbajo-Lozoya
MHMarco Y. Hein
Marco Y. Hein
MMMarcel A. Müller
Marcel A. Müller
WDWen Deng
Wen Deng
ABAlbrecht von Brunn
Albrecht von Brunn
Significance: Severe acute respiratory syndrome coronavirus (SARS-CoV) is one of the most pathogenic human coronaviruses. Virulence is reflected in the molecular interplay between virus and host cells. Here we show a strategy of how SARS-CoV antagonizes the host antiviral factor p53, which impairs viral replication. The papain-like protease of the nonstructural protein 3 of SARS-CoV and other coronaviruses physically interact with and stabilize E3 ubiquitin ligase ring-finger and CHY zinc-finger domain-containing 1 (RCHY1), thereby augmenting RCHY1-mediated degradation of p53. The SARS-unique domain (SUD) enhances these effects. Knockout of p53 promotes replication of SARS-CoV replicons and of infectious virus. Taken together we identify cellular p53 as antiviral measure of coronavirus-infected cells, which is counteracted via the stabilization of RCHY1 by viral SUD and papain-like protease (PL pro ) proteins and via ubiquitination of p53.

1 April 2012 in Virus Research
Verified
Journal Article
Closed access
JCJavier Carbajo-Lozoya
Javier Carbajo-Lozoya
MMMarcel A. Müller
Marcel A. Müller
SKStephan Kallies
Stephan Kallies
VTVolker Thiel
Volker Thiel
CDChristian Drosten
Christian Drosten
ABAlbrecht von Brunn
Albrecht von Brunn

1 May 2014 in Virus Research
Verified
Journal Article
Closed access
JCJavier Carbajo-Lozoya
Javier Carbajo-Lozoya
YMYue Ma-Lauer
Yue Ma-Lauer
MMMiroslav Malešević
Miroslav Malešević
MTMartin Theuerkorn
Martin Theuerkorn
VKViktoria Kahlert
Viktoria Kahlert
ABAlbrecht von Brunn
Albrecht von Brunn

1 January 2020 in Antiviral Research
Verified
Journal Article
Closed access
YMYue Ma-Lauer
Yue Ma-Lauer
YZYu Zheng
Yu Zheng
MMMiroslav Malešević
Miroslav Malešević
BBBrigitte von Brunn
Brigitte von Brunn
GFGunter Fischer
Gunter Fischer
ABAlbrecht von Brunn
Albrecht von Brunn

20 April 2021 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
JLJian Lei
Jian Lei
YMYue Ma-Lauer
Yue Ma-Lauer
YHYinze Han
Yinze Han
MTMatthias Thoms
Matthias Thoms
RBRobert Buschauer
Robert Buschauer
ABAlbrecht von Brunn
Albrecht von Brunn
The ongoing outbreak of severe acute respiratory syndrome (SARS) coronavirus 2 (SARS‐CoV‐2) demonstrates the continuous threat of emerging coronaviruses (CoVs) to public health. SARS‐CoV‐2 and SARS‐CoV share an otherwise non‐conserved part of non‐structural protein 3 (Nsp3), therefore named as “SARS‐unique domain” (SUD). We previously found a yeast‐2‐hybrid screen interaction of the SARS‐CoV SUD with human poly(A)‐binding protein (PABP)‐interacting protein 1 (Paip1), a stimulator of protein translation. Here, we validate SARS‐CoV SUD:Paip1 interaction by size‐exclusion chromatography, split‐yellow fluorescent protein, and co‐immunoprecipitation assays, and confirm such interaction also between the corresponding domain of SARS‐CoV‐2 and Paip1. The three‐dimensional structure of the N‐terminal domain of SARS‐CoV SUD (“macrodomain II”, Mac2) in complex with the middle domain of Paip1, determined by X‐ray crystallography and small‐angle X‐ray scattering, provides insights into the structural determinants of the complex formation. In cellulo , SUD enhances synthesis of viral but not host proteins via binding to Paip1 in pBAC‐SARS‐CoV replicon‐transfected cells. We propose a possible mechanism for stimulation of viral translation by the SUD of SARS‐CoV and SARS‐CoV‐2.